Sunlenca Product Label
Interaction Color Code
Clinical Bottom Line
Administer standard doses
Drug 1
Drug 1 effect
Not reported
Drug 2
Drug 2 dose
5 mg orally x 1
Drug 2 effect
AUC increased 31%; Cmax increased 57%
Clinical Effects
Potential for increased rosuvastatin adverse effects (e.g. myalgias, increased transaminases)
Info Source
